Mangesh Suryavanshi

Dr. Mangesh Suryavanshi

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2025 in Nature Reviews Nephrology
Verified
Journal Article
Open access
PDF file
PBPatricia Bloom
Patricia Bloom
WGWendy S. Garrett
Wendy S. Garrett
KPKristina L. Penniston
Kristina L. Penniston
MWMari-Karoliina H. Winkler
Mari-Karoliina H. Winkler
SHStanley L. Hazen
Stanley L. Hazen
JPJennifer L. Pluznick
Jennifer L. Pluznick
More than 850 million individuals worldwide, accounting for 10–15% of the adult population, are estimated to have chronic kidney disease. Each of these individuals is host to tens of trillions of microorganisms that are collectively referred to as microbiota — a dynamic ecosystem that both influences host health and is itself influenced by changes in the host. Available evidence supports the existence of functional connections between resident microorganisms and kidney health that are altered in the context of specific kidney diseases, including acute kidney injury, chronic kidney disease and renal stone disease. Moreover, promising data from preclinical studies suggest that targeting of gut microbial pathways may provide new therapeutic opportunities for the treatment of kidney disease. This Roadmap describes current understanding of the mechanisms by which microorganisms regulate host organ function, the effects of kidney disease on the gut microbiome, and how these insights may contribute to the development of microbe-targeted therapeutics. We highlight key knowledge gaps that remain to be addressed and strategies for addressing these, outlining both the promise and the potential pitfalls of leveraging our understanding of the gut microbiota to better understand and treat kidney disease.

29 August 2020 in Pathogens
Verified
Journal Article
Open access
PDF file
PRPD Rekha
PD Rekha
AHAsif Hameed
Asif Hameed
MMMUHAMMED MANZOOR
MUHAMMED MANZOOR
MSMangesh Suryavanshi
Mangesh Suryavanshi
SGSudeep D. Ghate
Sudeep D. Ghate
CYChiu-Chung Young
Chiu-Chung Young
Uropathogenic bacteria are widely distributed in the environment and urinary tract infection is implicated in kidney stone disease. Here, we report on a urease negative bacterium Kalamiella piersonii (strain YU22) isolated from the urine of a struvite stone (MgNH4PO4·6H2O) patient. The closest species, K. piersonii IIIF1SW-P2T was reported from International Space Station samples. However, there are no earlier reports on its human association. Using whole genome and experimental analysis, its involvement in urinary tract colonization and struvite crystallization was explored. The strain YU22 showed many virulence factors that are needed for host cell invasion and colonization including cell adhesion factors, swimming and swarming motilities, biofilm and siderophore among others. In vitro infection studies in HEK-293T cells demonstrated the host cell attachment and killing. It was able to utilize amino acids as sole carbon source and showed growth in synthetic and healthy urine establishing metabolic adaptation to urinary tract. Increased pH and availability of ammonium ions from amino acid breakdown promoted struvite crystallization. The results from this study support the involvement of urease negative uropathogen in the struvite lithogenesis. Further studies on other isolates of K. peirsonii are warranted to assess its health risks.

6 May 2023 in Genomics
Verified
Journal Article
Open access
CRC.T. Dhanya Raj
C.T. Dhanya Raj
MSMangesh Suryavanshi
Mangesh Suryavanshi
SKSurabhi Kandaswamy
Surabhi Kandaswamy
KRKesava Priyan Ramasamy
Kesava Priyan Ramasamy
ARArthur James Rathinam
Arthur James Rathinam
In this study, the probiotic potential of B. velezensis FCW2, isolated from naturally fermented coconut water, was investigated by in vitro and genomic characterization. Our findings highlight key features of the bacterium which includes, antibacterial activity, high adhesive potential, aggregation capacity, production of nutrient secondary metabolites. In vivo safety assessment revealed no adverse effects on zebrafish. WGS data of B. velezensis FCW2 revealed a complete circular genome of 4,147,426 nucleotides and a GC content of 45.87%. We have identified 4059 coding sequence (CDS) genes that encode proteins involved in stress resistance, adhesion and micronutrient production. The genes responsible for producing secondary metabolites, exopolysaccharides, and other beneficial nutrients were identified. The KEGG and COG databases revealed that genes mainly involved amino acid metabolism, carbohydrate utilization, vitamin and cofactor metabolism, and biological adhesion. These findings suggest that B. velezensis FCW2 could be a putative probiotic in the development of fermented foods.

2 January 2020 in Current Microbiology
Verified
Journal Article
Closed access
PDF file
SWSamadhan Waghmode
Samadhan Waghmode
SSSagar Swami
Sagar Swami
DSDhiman Sarkar
Dhiman Sarkar
MSMangesh Suryavanshi
Mangesh Suryavanshi
SRSneha Roachlani
Sneha Roachlani
SSSurekha Satpute
Surekha Satpute

9 November 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MSMangesh Suryavanshi
Mangesh Suryavanshi
SBShrikant S. Bhute
Shrikant S. Bhute
RGRahul P. Gune
Rahul P. Gune
YSYogesh Shouche
Yogesh Shouche
Analyses across all three domains of life are necessary to advance our understanding of taxonomic dysbiosis in human diseases. In the present study, we assessed gut microbiota (eubacteria, archaea, and eukaryotes) of recurrent oxalate kidney stone suffers to explore the extent of trans-domain and functional species dysbiosis inside the gut. Trans-domain taxonomic composition, active oxalate metabolizer and butyrate-producing diversity were explored by utilizing frc-, but-, and buk- functional gene amplicon analysis. Operational taxonomic units (OTUs) level analyses confound with the observation that dysbiosis in gut microbiota is not just limited to eubacteria species, but also to other domains like archaea and eukaryotes. We found that some of healthy eubacterial population retained together with Oxalobacter formigenes and Lactobacillus plantarum colonization in disease condition (p < 0.001 & FDR = 0.05). Interestingly, trans-domain species diversity has been less shared and dysgenic taxa augmentation was found to be higher. Oxalate metabolizing bacterial species (OMBS) and butyrate-producing eubacteria species were found to be decreased in Oxalobacter non-colonizers; and Prevotella and Ruminococcus species which may contribute to oxalate metabolism and butyrate synthesis as well. Our study underscores fact that microbial dysbiosis is not limited to eubacteria only hence suggest the necessity of the trans-domain surveillance in metabolic diseases for intervention studies.